Reaction
Uterine Leiomyosarcoma reporting signals
As of the last recalculation, Uterine Leiomyosarcoma appears in 80 FAERS reports alongside 1 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 207.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 17 | 207.3 | 207.4 |